![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Tariff hits to generic drugs could 'blow back on everybody' without supply chain resilience, says USP chief
Generic drugmakers will be uniquely vulnerable if the Trump administration rolls out pharmaceutical tariffs, thanks to just how “little resilience” the industry enjoys compared to its patented counterpart, CEO of the United States Pharmacopeia, Ronald Piervincenzi, said in an interview.
Generic drugmakers will be uniquely vulnerable if the Trump administration rolls out pharmaceutical tariffs, thanks to just how “little resilience” the industry enjoys compared to its patented counterpart, CEO of the United States Pharmacopeia, Ronald Piervincenzi, said in an interview.
